AKT Inhibitor Capivasertib as a Target for Osimertinib Combination Therapy in Lung Adenocarcinoma with EGFR Mutation - Takuya Tokunaga; Yuka Ishihara; Aya Harada Takeda; Yuya Tomioka; Ayako Nagata; Mayuko Kato; Takayuki Suetsugu; Keiko Mizuno; Kazuhiro Ueda; Naohiko Seki (Genes, 2026)